Network Pharmacology and Molecular Docking Approach to Reveal the Immunotherapeutic Mechanism of Cuscutae Semen in Treating Thin Endometrium

Figure 2

(a) Venn diagram of 70 druggable targets of CS which were also therapeutic targets of thin endometrium. (b) Disease-target-compound network based on the 10 bioactive compounds of CS and the 70 thin endometrium-CS common targets.

(a)

(b)